Reference - Detail
| RRC ID | 60651 |
|---|---|
| Author | Kim BJ, Kim BR, Kook YH, Kim BJ. |
| Title | Potential of recombinant Mycobacterium paragordonae expressing HIV-1 Gag as a prime vaccine for HIV-1 infection. |
| Journal | Sci Rep |
| Abstract |
Recombinant Mycobacterium strains such as recombinant BCG (rBCG) have received considerable attention for the HIV-1 vaccine development. Recently, we described a temperature-sensitive Mycobacterium paragordonae (Mpg) strain as a novel live tuberculosis vaccine that is safer and showed an enhanced protective effect against mycobacterial infection compared to BCG. We studied the possibility of developing a vaccine against HIV-1 infection using rMpg strain expressing the p24 antigen (rMpg-p24). We observed that rMpg-p24 can induce an increased p24 expression in infected antigen presenting cells (APCs) compared to rBCG-p24. We also observed that rMpg-p24 can induce enhanced p24 specific immune responses in vaccinated mice as evidenced by increased p24-specific T lymphocyte proliferation, gamma interferon induction, antibody production and cytotoxic T lymphocyte (CTL) responses. Furthermore, an rMpg-p24 prime and plasmid DNA boost showed an increased CTL response and antibody production compared to rBCG or rMpg alone. In summary, our study indicates that a live rMpg-p24 strain induced enhanced immune responses against HIV-1 Gag in vaccinated mice. Thus, rMpg-p24 may have potential as a preventive prime vaccine in a heterologous prime-boost regimen for HIV-1 infection. |
| Volume | 9(1) |
| Pages | 15515 |
| Published | 2019-10-29 |
| DOI | 10.1038/s41598-019-51875-6 |
| PII | 10.1038/s41598-019-51875-6 |
| PMID | 31664100 |
| PMC | PMC6820866 |
| MeSH | AIDS Vaccines / immunology* Animals Cell Proliferation Cytokines / biosynthesis Female Gene Products, gag / immunology* HIV Antibodies / biosynthesis HIV Infections / immunology HIV Infections / prevention & control* HIV-1 / genetics HIV-1 / immunology* Interferon-gamma / biosynthesis Mice Mice, Inbred BALB C Mycobacterium / genetics* Recombination, Genetic* T-Lymphocytes, Cytotoxic / immunology Vaccines, Synthetic / immunology |
| IF | 4.011 |
| Times Cited | 1 |
| Altmetric score |
オルトメトリクス指標項目
|
| The most frequently cited source | Patent(IFI CLAIMS) |
| Total number of mentions | 3 |
| Altmetric score changes over past 6months | 0.0 |
| Resource | |
| General Microbes | JCM18565 |